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Stress-induced precocious aging in
PD-patient iPSC-derived NSCs may underlie
the pathophysiology of Parkinson’s disease
Liang Zhu1, Chenxi Sun1, Jie Ren1, Guangming Wang 1, Rongjie Ma1, Lixin Sun1, Danjing Yang1, Shane Gao1,
Ke Ning1,2, Zhigang Wang3, Xu Chen4, Shengdi Chen5, Hongwen Zhu6, Zhengliang Gao7,8 and Jun Xu1
Abstract
Parkinson’s disease (PD) is an aging-related degenerative disorder arisen from the loss of dopaminergic neurons in
substantia nigra. Although many genetic mutations have been implicated to be genetically linked to PD, the low
incidence of familial PD carried with mutations suggests that there must be other factors such as oxidative stress,
mitochondrial dysfunction, accumulation of misfolded proteins, and enhanced inﬂammation, which are contributable
to the pathophysiology of PD. The major efforts of current research have been devoted to unravel the toxic effect of
multiple factors, which directly cause the degeneration of dopaminergic neurons in adulthood. Until recently, several
studies have demonstrated that NSCs had compromised proliferation and differentiation capacity in PD animal models
or PD patient-derived iPS models, suggesting that the pathology of PD may be rooted in some cellular aberrations at
early developmental stage but the mechanism remains to be elusive. Based on the early-onset PD patient-speciﬁc
iPSCs, we found that PD-patient iPSC-derived NSCs were more susceptible to stress and became functionally
compromised by radiation or oxidative insults. We further unraveled that stress-induced SIRT1 downregulation leading
to autophagic dysfunction, which were responsible for these deﬁcits in PD-NSCs. Mechanistically, we demonstrated
that stress-induced activation of p38 MAPK suppressed SIRT1 expression, which in turn augmented the acetylation of
multiple ATG proteins of autophagic complex and eventually led to autophagic deﬁcits. Our studies suggest that early
developmental deﬁcits may, at least partially, contribute to the pathology of PD and provide a new avenue for
developing better therapeutic interventions to PD.
Introduction
Parkinson’s disease (PD) is one of the most common
neurodegenerative diseases, which is characterized by
movement abnormalities of PD patients such as tremor,
rigidity, bradykinesia, and gait dysfunction1. The main
pathological feature of PD is the selective loss of dopa-
mine (DA) neurons in substantia nigra pars compacta of
midbrain accompanied by reduced dopaminergic inner-
vation of striatum as well as accumulation of Lewy bodies,
primarily composed of αα-Synuclein2,3. However, the
etiology of PD largely remains unknown4,5. One of the
reasons is probably due to the lack of human PD models,
which is incompetent to well recapitulate the genetic
background and the progression of the disease. With the
advent of the induced pluripotent stem cells (iPSCs)
technology6,7, it becomes realistic to generate iPSCs from
ﬁbroblasts of PD patients and subsequently differentiate
into DA neurons and potentially create human cell-based
PD disease models. Since then, a lot of familial and
© The Author(s) 2019
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Shengdi Chen (ruijincsd@126.com) or
Hongwen Zhu (hongwen_zhu@hotmail.com) or
Zhengliang Gao (zhengliang_gao@tongji.edu.cn) or
Jun Xu (1900912273@qq.com)
1East Hospital, Tongji University School of Medicine, Shanghai, China
2Department of Neuroscience, Shefﬁeld Institute for Translational
Neuroscience (SITraN), University of Shefﬁeld, Shefﬁeld, UK
Full list of author information is available at the end of the article.
These authors contributed equally: Liang Zhu, Chenxi Sun
Edited by B. Joseph
Ofﬁcial journal of the Cell Death Differentiation Association
1
2
3
4
5
6
7
8
9
0
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,
;
1
2
3
4
5
6
7
8
9
0
()
:,
;
sporadic PD iPSC lines as well as their isogenic control
lines by gene-editing, have been generated and provide
insightful clues regarding the mechanism of the disease8,9.
It is worthy of notice that some studies reported that PD
iPSCs manifested early developmental defects at the stage
of neural stem cells (NSCs)10. Consistently, several studies
in mouse models have proved that NSCs carrying the
SNCA mutation showed reduced proliferation, impaired
neurogenesis, and increased cell death11–14. NSCs from
transgenic mice expressing mutant LRRK2 exhibited
deﬁcient proliferation and reduced newborn neurons15,16.
It is likely that insults, which lead to the degeneration of
DA neurons may root at the very beginning of CNS
development.
In the current studies, we found that when treated with
irradiation or oxidative stress, NSCs derived from early-
onset PD patients showed precocious senescence as well
as compromised proliferation and neuronal differentia-
tion. We further proved that stress-induced down-
regulation of SIRT1, which subsequently led to the
autophagic dysfunction, was essential for the aforemen-
tioned phenotypes. Moreover, the defects in PD-NSCs
would affect the development of brain organoids. These
ﬁndings provided compelling evidence to support the idea
that early developmental deﬁcits in PD may contribute to
the decline of DA neuron pool in adulthood and the
molecular mechanism outlined in this study might facil-
itate the development of novel diagnostic and therapeutic
maneuvers for ﬁghting PD.
Results
Generation and characterization of human iPSCs from
adult human dermal ﬁbroblasts of PD patients
We got skin tissues from two early-onset idiopathic PD
patients and one healthy individual as control by skin
biopsy. One of the patients was a 35-year-old male PD
patient with the disease onset at the age of 28 while
another 21-year-old male with onset at age 19. The
healthy control was a 28-year-old male with no history of
neurological disease.
Human ﬁbroblasts were isolated and expanded and
their identities were conﬁrmed by TE-7 staining (Fig. S2a).
First, we conducted genetic analyses of genomic DNA by
using whole-exome sequencing. All the detailed results
were listed in Supplementary Table 1. In order to conﬁrm
these point mutations revealed by whole-exome sequen-
cing, we identiﬁed them by using PCR assays and DNA-
sequencing analysis. A rare insertion mutation in phos-
pholipase A2, group VI (PLA2G6), c.28dupA (p.T10fs),
was identiﬁed in the sample from 35-year-old PD patient
(PD-ﬁbroblasts) (Fig. S1a). The insertion mutation
c.28dupA (p.T10fs) in PLA2G6 could cause a frameshift.
We also found a potentially deleterious splice-site
mutation c.292-1G > A within Parkin co-regulated gene
(PACRG) in PD-S-ﬁbroblasts (Fig. S1b), which derived
from the 21-year-old PD patient, leading to an abnormal
splice-site variants. Also, in addition to the two identiﬁed
mutations, we couldn’t exclude that there were other
mutations as revealed by whole-exome sequencing in PD
samples.
Then skin ﬁbroblasts were reprogrammed with stan-
dard methods. We picked 10–20 human embryonic stem
cell (hESC)-like colonies per individual for further
expansion, totaling 50 iPSC lines. At least 2 iPSC lines per
patient and 2 iPSC lines per healthy control were thor-
oughly characterized and sustained long-term passaging
(>20 passages) and then differentiated into neural stem
cells for detailed analysis.
Both iPSCs from PD patients and from healthy control
exhibited morphology similar to hESCs and were stained
positively by alkaline phosphatase and typical hESC markers
such as OCT4, NANOG, TRA1-60, TRA1-81, SSEA3, and
SSEA4 (Fig. S2b, c). Reverse transcription-PCR (RT-PCR)
analysis showed that iPSCs expressed many hESC-marker
genes, such as SOX2, OCT4, c-MYC, KLF4, NANOG,
LIN28, and REX1 (Fig. S2d). Further analysis showed that
iPSCs were hypomethylated at the OCT4 promoter regions
compared to ﬁbroblasts (Fig. S2e). These human iPSCs
were able to differentiate into cells of three germ layers
spontaneously in vitro, which were stained positively
for βIII-tubulin (Tuj1, a marker of ectoderm), α-SMA
(mesoderm), and AFP (endoderm) (Fig. S2f). Real-time
quantitative PCR (Q-PCR) and RT-PCR conﬁrmed that
these differentiated cells expressed characteristic genes of
three germ layers including SOX17, AFP, and FOXA
(endoderm markers); SMA, BRACHYURY, and MSX1
(mesoderm markers); and GFAP, PAX6, and NCAM
(ectoderm) (Fig. S2g, h). The teratoma contained tissues
from all three germ layers including neural tissues
(ectoderm), cartilage (mesoderm), and gut-like epithelial
tissues (endoderm) (Fig. S2i). Taken together, all these
iPSCs were very similar to hESCs in terms of cell
morphology, pluripotency, gene markers, differentiation
potency, and epigenetics.
NSCs derived from PD patients manifest compromised
proliferation and differentiation capacity and are
susceptible to genotoxic stress
As aforementioned that the pathology of PD may start
as early as NSC stage10, we investigated the differences
between NSCs derived from PD patients (PD-NSCs,
35-year-old male and PD-S-NSCs, 21-year-old male) and
healthy individual (WT-NSCs, 28-year-old male). All
these NSCs expressed typical NSC markers Nestin and
SOX2 with high purity (over 95%, Fig. 1a). Upon withdraw
of basic ﬁbroblast growth factor (bFGF), we observed that
WT-NSCs spontaneously differentiated into Tuj1-positive
neurons (42%) and GFAP-positive astrocytes (50%),
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whereas only less than one-third of PD-NSCs started
spontaneous differentiation (Fig. 1b, c). Meanwhile, the
proliferative capacity of PD-NSCs also reduced slightly as
evaluated by cell counting kit-8 (CCK8) assays and
Ki67 staining compared with WT-NSCs (Fig. 1d–f).
We further examined whether PD-NSCs were more
susceptible to genotoxic stress by exposure to ionizing
radiation (IR, 10 Gy of X-ray). PD-NSCs were more prone
to become senescent than WT-NSCs, when insulted by
IR, as estimated by SA-β-gal staining (Fig. 1g, h). We also
observed these senescent phenotypes in NSCs derived
from 21-year-old early-onset PD patient (PD-S-NSCs)
(Fig. S4). The reactive oxygen species (ROS) level of
PD-NSCs increased dramatically 48 h after IR treatment
(5.2 folds) compared with wild-type (WT) control
(2.3 folds) (Fig. 1i, j). The number of actively dividing
NSCs (Ki67-positive) decreased more rapidly in PD-NSCs
than WT-NSCs (3.8 folds vs 2.2 folds, Fig. 1k, l),
which was accompanied by far more DSB DNA damage
(γH2AX-positive foci) accumulation in PD-NSCs
(Fig. 1m, n). PD-NSCs demonstrated most compromised
proliferative ability when treated by IR (Fig. 1o). Mean-
while, IR treatment elicited a signiﬁcant elevated expres-
sion of p16, p21, and p53, which were key regulators
of cell senescence, in PD-NSCs with little effect in
WT-NSCs (Fig. 1p).
SIRT1 plays an essential role in regulating the precocious
aging of PD-NSCs induced by genotoxic stress
SIRT1 is class III histone deacetylases, which can regulate
cellular senescence17–19. Given that we sought to explore
whether the premature aging of PD-NSCs was attributable
to stress response of SIRT1. We found that the protein level
of SIRT1 reduced markedly 48 h after IR treatment in PD-
NSCs, whereas no signiﬁcant changes detected in WT-
NSCs (Fig. 2a). Similarly, SIRT1 was also downregulated by
oxidative stress when treated with 1-Methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) and H2O2 in PD-NSCs
(Fig. 2b), suggesting that downregulation of SIRT1 was a
general stress response speciﬁc for PD-NSCs. Also, as
results showed in Fig. S6a, the reduced expression of SIRT1
was observed in PD-S-NSCs treated with oxidative stress.
Cells with serial passaging (passage 20 and above) could
resemble cellular aging10. We investigated the SIRT1 pro-
tein level in senile PD-S-NSCs at late passages. The results
showed that SIRT1 expression in PD-S-NSCs at passage 25
was much lower than that in WT-NSCs (Fig. S6b).
We treated PD-NSCs with resveratrol, a well-known
activator of SIRT1. Resveratrol partially rescued the
senescence of PD-NSCs in response to IR and preserved
more proliferative NSCs as revealed by SA-β-gal and
Ki67 staining, respectively (Fig. 2c–f). The results also
showed that resveratrol could resist the premature aging
of PD-S-NSCs (Fig. S5). Consistently, activation of SIRT1
by resveratrol blocked the upregulation of p53, p21, and
p16 in PD-NSCs after IR (Fig. 2g) and largely abolished
the reduction of SIRT1 expression induced by IR (Fig. 2g).
We sought to knockdown SIRT1 in WT-NSCs with a
recombinant lentivirus encoding SIRT1 short hairpin
RNA (shRNA) (Fig. 3c). Knockdown of SIRT1 only
slightly made WT-NSCs more senescent while greatly
aggravated the senescence of WT-NSCs upon IR treat-
ment (Fig. 3a, b), accompanied by augmented expression
of several aging-related genes such as p53, p21, and p16
(Fig. 3c). Coincidentally, the proliferative NSCs were
almost completely depleted by SIRT1 KD in WT-NSCs
when challenged by IR (Fig. 3d, e). As expected, the DNA
damage accumulation rocketed when insulted by IR in the
absence of SIRT1 (Fig. 3f, g). These data suggested that
SIRT1 downregulation was sufﬁcient to predispose NSCs
(see ﬁgure on previous page)
Fig. 1 NSCs derived from patient-speciﬁc PD iPSCs manifested premature aging phenotypes and were sensitive to irradiation. a iPSC-
derived neural stem cells were stained positively for NSC-speciﬁc markers Nestin and SOX2. Scale bar: 100 μm. b, c Neural differentiation capacity was
severely impaired in PD iPSCs. b The representative images for spontaneous differentiation of PD- and WT-NSCs toward neurons and astrocytes as
determined by the neuronal marker (Tuj1) and the astrocyte marker (GFAP). c Statistic results showed the percentage of Tuj1 and GFAP cells out of all
cells derived from WT- and PD iPSCs. Scale bar: 100 μm. d–f The proliferative capacity of PD-NSCs was compromised as revealed by CCK8 assays and
Ki67 staining. d Cell growth curve was detected by CCK8 assays at 24, 48, 72, 96, and 120 h. e Proliferation capacity was determined by Ki67 staining.
f Graph showed the percentage of Ki67 cells. Scale bar: 100 μm. g, h Cellular senescence was signiﬁcantly aggravated by IR treatment as evaluated
with the SA-β-gal assay. g Representative images from at least three independent experiments were presented. h The statistical results showed the
percent of SA-β-gal-positive cells (%). Scale bar: 100 μm. i, j ROS level increased signiﬁcantly in PD-NSC with IR treatment. i Cellular ROS was stained
with DCF-DA and observed under a ﬂuorescence microscope. j ROS level was detected by ﬂuorescence microplate reader. Scale bar: 100 μm.
k, l Proliferative capacity was further decreased in PD-NSCs after IR treatment as revealed by Ki67 staining. k Expression of Ki67 in cells with or without
IR treatment. l Graph showed the ratio of Ki67-positive cells. Scale bar: 100 μm.m, n DNA damage accumulation increased dramatically in PD-NSCs by
IR as revealed by γH2AX staining (red) at 48 h post IR treatment. m Formation of DNA double-strand breaks in NSCs post irradiation. n Graphical
depiction indicated the number of γH2AX foci in NSCs. Scale bar: 10 μm. o Cell proliferation curve of WT-NSCs and PD-NSCs with or without IR. Cell
numbers were analyzed at 24, 48, 72, 96, and 120 h. p The expression level of cell senescence markers p53, p21, and p16 was augmented in PD-NSCs
with IR treatment, analyzed by western blotting and densitometry. NSCs were treated with 10 Gy of IR and incubated for the indicated periods.
β-actin was used as the loading control. All the data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ns not statistically signiﬁcant,
Student’s t-test. All data were obtained from at least three independent experiments
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to become prematurely aged in response to stress. We
attempt to rescue these aging phenotypes in PD-NSCs by
overexpression of SIRT1. Indeed, the ectopic expression
of SIRT1 led to a signiﬁcant increase in Ki67 activity in
PD-NSCs and the depletion of proliferative cells by IR was
markedly inhibited (Fig. 3h, i). IR-induced upregulation of
a spectrum of aging genes (p53, p21, and p16) was also
nearly completely blocked by SIRT1 overexpression
(Fig. 3j). Taken together, these data proved that SIRT1
played a pivotal role in maintaining the juvenescence and
stemness of NSCs.
SIRT1 expression level is modulated by p-p38 activities in
PD-NSCs in response to IR
Some studies reported that p38 kinase could modulate
the degradation of SIRT120 and be involved in the onset of
cellular senescence21–23. Given that we investigated how
p38 kinase modulated the expression of SIRT1. As shown
in Fig. 4a, IR triggered a signiﬁcant increase of the
phosphorylation of p38 in PD-NSCs. However, the p-p38
level in WT-NSCs remained almost unaltered. Adminis-
tration of p38 kinase-speciﬁc inhibitor, SB203580, almost
completely blocked IR-induced downregulation of SIRT1
in PD-NSCs (Fig. 4a). Subsequently, by inhibition of p38
activities, the IR-triggered senescence was largely pre-
vented (Fig. 4b) and the upregulation of aging-related
genes, such as p53, p21, and p16 were signiﬁcantly sup-
pressed (Fig. 4c). Our data collectively suggested that
p-p38 acted as an upstream regulator of SIRT1 and par-
ticipated in the aging of PD-NSCs.
Autophagic dysfunction is responsible for the stress-
induced premature aging of PD-NSCs
Autophagy, which could degrade misfolded proteins
or injured organelles, is considered as a key survival
mechanism in aging process24–29. Therefore, it is intri-
guing to explore whether autophagic function is altered in
PD-NSCs and attributable to aforementioned phenotypes.
We observed the downregulation of autophagy-related
gene BECN1 in PD-NSCs after IR exposure both by
western blot and Q-PCR (Fig. 5a, b). Other key players in
maintaining normal function of autophagy such as ATG5,
7, 12, LC3B et al. were also downregulated by IR in PD-
NSCs while the expression of mTOR, the inhibitor of
autophagy, was signiﬁcantly augmented (Fig. 5b).
Consistently, the number of cytosolic autophagosome
puncta revealed by LC3B staining decreased signiﬁcantly
in PD-NSCs by IR treatment (Fig. 5c). We also observed
the same deﬁcient phenotypes in PD-S-NSCs (Fig. S7).
Furthermore, the results from electron microscopy ana-
lysis conﬁrmed that there was little change in the number
of autophage vacuoles (AVs) in WT-NSCs after oxidative
stress treatment, while marked reduction of AVs was
induced in PD-NSCs (Fig. 5d, e). We then assessed
autophagic function using RFP-GFP-LC3 vector. The
number of autophagosomes (as indicated by yellow
puncta) decreased after treatment with H2O2, and this
tendency was more signiﬁcant in PD-NSCs compared
with WT-NSCs (Fig. 5f, g). These data strongly suggested
that autophagy induction was blocked in PD-NSCs after
stress exposure.
To further elucidate whether autophagic dysfunction
contributes to the premature aging of PD-NSCs, we treated
PD-NSCs with the activator and inhibitor of autophagy,
rapamycin and chloroquine respectively while exposed to
IR. Rapamycin almost reversed the senescent phenotype of
PD-NSCs, whereas chloroquine further aggravated it
(Fig. 6a, b). Also rapamycin could resist the premature aging
of PD-S-NSCs (Fig. S5). Consistently, in PD-NSCs, the
expression of aging-related genes, p53, p21, and p16 were
reduced by rapamycin and enhanced by chloroquine
(Fig. 6c). Moreover, IR-induced compromised proliferation
could be largely rescued by rapamycin while chloroquine
almost abolished that (Fig. 6d, e). These data jointly
demonstrated that autophagic dysfunction could endow the
precocious aging phenotypes in PD-NSCs.
Autophagic dysfunction in PD-NSCs induced by IR is
attributable to the downregulation of SIRT1
Recent studies have reported that SIRT1 is capable of
stimulating basal activities of autophagy30–33. Therefore,
we sought to investigate whether loss of SIRT1 in PD-
NSCs could lead to impairment of autophagy. When
treated with resveratrol, IR-induced downregulation of
BECN1 was almost reversed (Fig. 7a). Consistently,
Q-PCR analysis revealed that in PD-NSCs challenged by
IR, a spectrum of autophagy-related genes, such as
ATG5/7/12 and LC3B responded to resveratrol similarly
as BECN1 while mTOR expression was reduced (Fig. 7b).
Consequently, LC3B expression was also augmented
(see ﬁgure on previous page)
Fig. 2 SIRT1 was downregulated in PD-NSCs by various stresses, which was attributable for the premature aging phenotypes. a, b SIRT1
expression in PD-NSCs was signiﬁcantly reduced by various stresses including IR, MPTP, and oxidative stress treatment, analyzed by western blotting
and densitometry. WT-NSCs and PD-NSCs were treated with 10 Gy of IR, 500 μM MPTP, and 100 μM H2O2, respectively, and then cultured for 48 h
before western blot. c, d IR-induced cell senescence was largely attenuated by activation of SIRT1 in the presence of 3 μM resveratrol. e, f Resveratrol
partially rescued the declined proliferative capacity (Ki67 staining) of PD-NSCs after IR treatment. g Induction of aging-related genes in PD-NSCs by IR
treatment was prevented by resveratrol, analyzed by western blotting and densitometry. All data were obtained from at least three independent
experiments; mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001, ns not statistically signiﬁcant, Student’s t-test. Scale bar: 100 μm
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by resveratrol (Fig. 7c). These data indicated that activa-
tion of SIRT1 attenuated the IR-induced autophagy
dysfunction.
We further found that suppression of SIRT1 attenuated
BECN1 protein level without IR treatment while IR could
further reduce the BECN1 expression (Fig. 7d), which
basically represented the similar tendency for a pan of
(see ﬁgure on previous page)
Fig. 3 SIRT1 regulated the aging process of PD-NSCs after IR. a, b Cell senescence induced by IR was aggravated by downregulation of SIRT1 in
WT-NSCs. WT-NSCs infected with SIRT1 shRNA were exposed to 10 Gy IR and incubated for 48 h. Scale bar: 100 μm. c Protein levels of aging-related
genes in WT-NSCs with Sirt1 knockdown increased signiﬁcantly, analyzed by western blotting and densitometry. d, e The expression of Ki67
decreased by knockdown of Sirt1 in WT-NSCs after IR treatment. Scale bar: 100 μm. f, g DNA damage accumulation represented by γH2AX foci
enhanced dramatically in WT-NSCs with downregulated Sirt1 expression at 48 h post IR treatment. Scale bar: 10 μm. h, i Proliferative capacity as
revealed by Ki67 staining was increased by overexpression of Sirt1 in PD-NSCs after IR treatment. SIRT1 expression in PD-NSCs was increased using a
recombinant lentivirus encoding wild-type SIRT1, then cells were exposed to 10 Gy IR and incubated for 48 h. Scale bar: 100 μm. j Aging-related
genes in PD-NSCs with Sirt1 overexpression further decreased, analyzed by western blotting and densitometry. All data were obtained from at least
three independent experiments; mean ± SD, ***P < 0.001, **P < 0.01, *P < 0.05, ns not statistically signiﬁcant, Student’s t-test
Fig. 4 p-p38 could modulate SIRT1 expression in PD-NSCs after IR. a Gene expression of pP38 and SIRT1 was detected by western blot in WT-
NSCs and PD-NSCs in the presence of p38 kinase-speciﬁc inhibitor, SB203580, analyzed by western blotting and densitometry. NSCs were irradiated
10 Gy and then incubated for 48 h in absence or presence of 20 μM SB203580. b IR-induced cell senescence was largely alleviated by suppression of
pP38 in the presence of 20 μM SB203580. c The expression of aging-related genes p16, p21, and p53 was further decreased in PD-NSCs in the
presence of 20 μM SB203580, analyzed by western blotting and densitometry. Data represent the mean ± SD of three independent experiments.
Statistical analysis was performed by Student’s t-test, ***P < 0.001, **P < 0.01, *P < 0.05, ns not statistically signiﬁcant. All data were obtained from at
least three independent experiments. Scale bar= 100 μm
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autophagic genes (Fig. 7e). Similarly, SIRT1 knockdown
itself reduced LC3B expression while IR treatment simply
aggravated it (Fig. 7f). Furthermore, we found that upre-
gulation of SIRT1 in PD-NSCs led to increased level of
BECN1 and the IR-induced reduction of BECN1 was
markedly recovered (Fig. 7g). We also found that
senescence-induced suppression of LC3B was attenuated
in PD-NSCs with SIRT1 upregulation (Fig. 7h). All these
results proved that SIRT1 downregulation endowed the
autophagic dysfunction in PD-NSCs, especially under
genotoxic stress.
SIRT1 can directly interact with autophagy machinery and
regulate autophagic function
We treated cells with SIRT1 activator resveratrol and
autophagy inhibitor chloroquine combined with IR
(see ﬁgure on previous page)
Fig. 5 PD-NSCs showed autophagy dysfunction during the aging process after IR. a BECN1 expression in PD-NSCs after irradiation treatment
was signiﬁcantly decreased as revealed by western blot and densitometric analysis. b The mRNA expression of several genes linked with autophagy
function, such as BECN1, LC3B, ATG5, ATG7, and ATG12, was consistently decreased in PD-NSCs with IR treatment. c The expression of LC3B in PD-NSCs
with irradiation was further reduced as detected by immunostaing. Scale bar: 10 μm. d, e The double membrane structures of autophagy vacuoles in
PD-NSCs after oxidative stress were decreased as analyzed by electron microscope under a JEM 1010 transmission electron microscope. NSCs were
treated with H2O2 and incubated for 48 h, and then were ﬁxed and stained. The yellow asterisk indicated autophagic vacuoles, including
autophagosomes. Scale bar: 0.5 μm. f, g Distribution of GFP-LC3 in PD-NSCs changed dramatically under post-H2O2 conditions. After cells were
treated with H2O2 for 48 h, they were infected with RFP-GFP-LC3 virus. Scale bar: 50 μm. All the data were expressed as mean ± SD from three
independent experiments. Statistical analysis was performed by Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.001; ns not statistically signiﬁcant. All
data were obtained from at least three independent experiments
Fig. 6 Autophagy was implicated in the IR-induced premature aging of PD-NSCs. a, b Cell senescence induced by irradiation was detected by
SA-β-gal staining in the presence of rapamycin or chloroquine. Cells were exposed to 10 Gy X-ray in the presence of 0.04 μM rapamycin or 3 μM
chloroquine, incubated for 48 h, and then stained with SA-β-gal. c p16, p21, and p53 expression from rapamycin- or chloroquine-treated NSCs were
detected by western blotting and densitometry. d, e The effect of rapamycin or chloroquine on Ki67 expression was visualized by immunostaining.
Data represent as the mean ± SD of three independent experiments. Statistical analysis was performed by Student’s t-test, *P < 0.05, **P < 0.01, ***P <
0.001. All data were obtained from at least three independent experiments. Scale bar= 100 μm
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exposure. Resveratrol could partially reverse the senes-
cence induced by IR, whereas this effect was largely
abolished by chloroquine (Fig. 8a, b). Meanwhile, chlor-
oquine itself could further aggravate the IR-induced
senescence of PD-NSCs. Consistently, the resveratrol-
induced reduction of aging-related genes, P53, P21, and
P16, in PD-NSCs upon IR treatment was inhibited by
chloroquine exposure (Fig. 8c). Additionally, resveratrol
could signiﬁcantly attenuate H2O2-induced augment of
premature aging in PD-NSCs, which was largely blocked
by disrupting the autophagy function through BECN1
knockdown (Fig. 8d, e). These results suggested that IR-
induced autophagic dysfunction was a downstream effect
of SIRT1 downregulation.
To further conﬁrm that SIRT1 might interact directly
with some components of autophagy machinery, we
assessed the interaction between SIRT1 and some essen-
tial autophagy genes, such as BECN1 and LC3B by
Fig. 7 SIRT1 could regulate autophagy in the aging process of PD-NSCs. a Reduction of BECN1 protein levels in PD-NSCs by IR treatment was
restored by 3 μM resveratrol treatment, analyzed by western blotting and densitometry. b The decrease of mRNA expression of autophagy-related
genes, such as BECN1, LC3B, ATG5, ATG7, and ATG12 in PD-NSCs treated with IR was prevented by administration of 3 μM resveratrol. c The suppression
of LC3B expression in PD-NSCs after IR treatment was restored in the presence of 3 μM resveratrol. d The expression of BECN1 in WT-NSCs with Sirt1
knockdown decreased signiﬁcantly compared with control group, analyzed by western blotting and densitometry. e The mRNA expression of
autophagy-related genes, such as BECN1, LC3B, ATG5, ATG7, and ATG12 in WT-NSCs treated with IR was further reduced when Sirt1 expression was
inhibited. f The expression of LC3B decreased by knockdown of Sirt1 in WT-NSCs after IR treatment. g The decline of BECN1 expression in PD-NSCs
after IR was inhibited by overexpression of Sirt1, analyzed by western blotting and densitometry. h The reduction of LC3B in PD-NSCs post IR was
alleviated after Sirt1 was upregulated. The data were expressed as mean ± SD from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001,
ns not statistically signiﬁcant, Student’s t-test. All data were obtained from at least three independent experiments. Scale bar= 100 μm
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immunoprecipitation. As shown in Fig. 8f, there was
remarkable interaction of SIRT1 with either BECN1 or
LC3B. Some studies proved that SIRT1, as a deacetylase,
could enhance basal autophagy by deacetylating ATG5,
ATG7, and ATG833. Inactivation of BECN1 protein
induced by augmented acetylation could be achieved by
SIRT1 inhibition34. Our results showed that BECN1 and
LC3B acetylation levels signiﬁcantly increased after H2O2
exposure, which could be prevented partially by resvera-
trol (Fig. 8g). We also found that treatment of cells with
SIRT1 inhibitor nicotinamide had an enhanced effect on
BECN1 and LC3B acetylation (Fig. 8h). These results
suggested that stress-induced downregulation of SIRT1 in
PD-NSCs could cause autophagy deﬁcits by increasing
acetylation levels of autophagy proteins, which eventually
lead to premature aging of PD-NSCs.
PD iPSCs display deﬁciency in the development of brain
organoids
Recently, human brain organoids were used to recapi-
tulate brain development and disease progress35,36. To
explore whether the defects we observed at stage of NSCs
affect the development of brain organoids, we investigated
the differences between WT and PD organoids. As shown
in Fig. S3, organoids derived from WT iPSCs showed
smooth edges and optically translucent surface tissue
consistent with neuroectoderm, while organoids from PD
iPSCs lacked optical clearing and translucent neuroecto-
derm and large amounts of cell debris accumulated,
suggesting failed neural induction. Moreover, the sizes of
PD organoids were much smaller than WT group, which
further proved that PD iPSCs displayed developmental
drawbacks of brain organoids.
Discussion
Several PD-related genes had been shown to play roles
in embryonic or adult neurogenesis. The deﬁciency in
LRRK2, VPS35, SNCA, and PINK1 led to deregulated
embryonic neurogenesis and neurite outgrowth37–40.
Adult neurogenesis was also affected in both PD patients
and PD animal models with mutant forms of PD-related
genes. NSCs from transgenic mice expressing mutant
LRRK2 exhibited deﬁcient proliferation and reduced
newborn neurons15,16. NSCs carrying the SNCA mutation
manifested reduced proliferation, impaired neurogenesis,
and increased cell death11–14. Other PD-related genes,
such as VPS35, Parkin, PINK1, and DJ-1 et al., also played
important roles in the proliferation or maintenance of
NSCs, neural progenitor cells, or iPSCs. Postmortem
brain tissues of PD patients were found to have decreased
proliferating cell nuclear antigen (PCNA)-positive cells as
well as reduced nestin-positive precursor cells in olfactory
bulb and dentate gyrus41,42. Liu et al. found that PD
patient-derived NSCs, which carried LRRK2 (G2019S)
mutation, showed increased susceptibility to proteasomal
stress and passage-dependent deﬁciencies in proliferation
and neuronal differentiation10. Taken together, these
studies strongly suggested the potential correlation
between deregulated neurogenesis and pathophysiology of
PD. In our studies, we found that early-onset PD patient-
derived NSCs possessed susceptibility of premature aging
in respond to IR exposure. These ﬁndings provide com-
pelling evidence to support the role of early develop-
mental deﬁcits in the pathogenesis of PD. However, the
regulatory mechanisms underlying PD-NSCs senescence
as well as its correlation with PD pathology remain largely
ambiguous.
We generated iPSCs lines from two patients with idio-
pathic early-onset PD. We identiﬁed an insertion muta-
tion in PLA2G6 and an essential splice-site mutation in
PACRG respectively in samples from the two patients.
PLA2G6 is the causative gene for PARK14-linked par-
kinsonism, which is a juvenile-onset parkinsonism43.
Mutations in PLA2G6 could cause neurodegeneration
including infantile neuroaxonal dystrophy and adult-onset
dystonia parkinsonism44,45. PACRG is a gene that is
transcriptionally co-regulated with the parkin gene by a
bi-directional promoter46. Many reports demonstrated
(see ﬁgure on previous page)
Fig. 8 SIRT1 regulated autophagy through physically interacted with and deacetylated BECN1 and LC3B in PD-NSCs. a–c Cell senescence of
PD-NSCs treated with or without resveratrol or chloroquine was measured, including SA-β-gal staining (a, b) and expression of aging-related genes
(c), analyzed by western blotting and densitometry. Cells were exposed to 10 Gy X-ray in the presence of 3 μM resveratrol or 3 μM chloroquine, and
then incubated for 48 h. d, e Images of cellular senescence in PD-NSCs after knockdown of BECN1 were visualized using SA-β-gal assay. Cells were
transfected with siBECN1, and then exposed to 10 Gy X-ray in the presence of 3 μM resveratrol, incubated for 48 h. f The interaction between SIRT1
and autophagy-related genes, LC3B and BECN1, in PD-NSCs. Cell lysates were immunoprecipitated with anti-SIRT1 or control IgG antibody; and then,
reciprocally probed with anti-BECN1 and anti-LC3B. Cell lysates were immunoprecipitated with anti-BECN1, anti-LC3B, or control IgG antibody; and
then, reciprocally probed with anti-SIRT1. g Western blot and densitometric analysis of acetylation changes of BECN1 and LC3B after IR treatment in
PD-NSCs. BECN1 and LC3B were immunoprecipitated from the total cell lysate of NSCs by BECN1 and LC3B antibody; and then, western blots were
probed with anti-acetylated lysine antibody. h Western blot and densitometric analysis of acetylation changes of BECN1 and LC3B after PD-NSCs
were treated with SIRT1 activator resveratrol (3 μM) and SIRT1 inhibitor nicotinamide (5 mM). BECN1 and LC3B were immunoprecipitated from the
total cell lysate of NSCs by BECN1 and LC3B antibody; and then, western blots were probed with anti-acetylated lysine antibody. Data of the graph
were expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test. All data were obtained from at least three independent
experiments. Scale bar= 100 μm
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that mutations in PACRG were associated with familial
and also sporadic, early-onset PD47–49. However, we
didn’t know whether the two mutations were associated
with the senescence and regulatory mechanism of NSCs
derived from PD patients.
In our study, we found that IR treatment could lead to
downregulation of SIRT1 in PD-NSCs. This phenomenon
is similar to that observed in endothelial cells whereby
cellular senescence is attributable for the development of
age-related diseases, such as atherosclerosis20. Our results
collectively suggested that SIRT1 played an essential role
in controlling cellular senescence of NSCs. In this study,
we observed that PD-NSCs were more susceptible to
autophagy dysfunction in response to IR. The senescence
could be largely reversed by boosting the autophagic
function and otherwise aggravated by further blocking the
autophagy. We further demonstrated that stress-induced
SIRT1 reduction could account for the autophagic dys-
function and eventually lead to cellular senescence of PD-
NSCs. It is of paramount importance to determine whe-
ther these mutations carried by patients have anything to
do with the susceptibility of SIRT1 and autophagy
to stresses at the stage of NSCs, which, in turn, contribute
to pathogenesis of PD.
In summary, we demonstrated that the NSCs, which
were derived from early-onset PD patients, manifested
susceptibility to various stresses and were prone to
become more senescent. Also, we outlined a relatively
clear picture of the molecular mechanism of PD pathol-
ogy from different perspective that dysregulation of SIRT1
was a pivotal player in endowing NSCs the susceptibility
to stress by modulating autophagy activity. Based on this
study, in combination with other previous reports, it is
tempting to hypothesize that developmental defects,
which might contribute to constraining the pool size of
DA neuron number when growing into adulthood, could
have profound impact on the onset timing and the
severity of progression of PD. To consolidate this
hypothesis, there are still a few critical questions to be
addressed. First of all, it is essential to know whether the
deﬁcits we observed at the stage of NSCs will only pre-
ferentially affect the genesis of DA neurons. Second, it
needs to be clariﬁed how the mutations carried by PD
patients regulate the SIRT1 and autophagy as well as the
subsequent signaling pathways.
Owing to the limited number of early-onset PD patients,
we were not 100% sure that the premature aging of PD-
NSCs and regulatory mechanisms could be repetitive in
all idiopathic early-onset PD patients. However, these
results indicated the possibility that the senescent phe-
notypes, deﬁcient SIRT1 expression, and dysfunctional
autophagy in PD-NSCs might contribute to the defects of
dopaminergic neuron pools and other neurodegenerative
disorder associated with PD pathology. We can use this
knowledge to formulate a novel paradigm of analysis to
better predict the onset and the progression of PD and
provide a preventive intervention toward the cure of the
disease.
Materials and methods
Clinical data for patient-speciﬁc iPSC lines
In this study, we recruited individuals from Han Chi-
nese population. Individuals in each group were also
selected so that no signiﬁcant bias in gender or age
occurred.
We obtained PD patients’ skin tissues from Ruijin
Hospital afﬁliated to Shanghai Jiaotong University School
of Medicine. The iPSC lines were generated from two
subjects with idiopathic early-onset PD under informed
consent. Subject 1 was a 35-year-old male and carried a
rare homozygous insertion within PLA2G6 c.28dupA (p.
T10fs), with no family history of PD. The age of onset of
this PD patient with PLA2G6 mutation was 28 years. He
had a score of 2.5 on the Hoehn and Yahr scale and
showed serious resting tremor. Subject 2 was a 21-year-
old man and diagnosed with idiopathic PD at age 19, with
no family history of the disease. He had a potentially
deleterious PACRG splice-site mutation, c.292-1G > A
mutation. He had a score of 3.5 on the Hoehn and Yahr
scale, indicating severe disability.
The healthy individual in our study was a 28-year-old
male and had no history of neurological disease.
Generation of human skin ﬁbroblast-derived iPSCs
Fibroblasts were isolated and ampliﬁed, then were
infected with retroviruses expressing OCT4, SOX2,
Nanog, and KLF4, and maintained in hESC medium on
iMEF feeder cells. After 30 days induction, the skin cells
were reprogrammed into iPSCs. Ten to twenty indepen-
dent iPSC lines per individual were generated, totaling 50
iPSC lines. Two iPSC lines per patient were thoroughly
characterized and sustained long-term passaging (>20
passages) and then differentiated into neural progenitors
for detailed analysis.
iPSC culture and neural induction
iPSCs were plated onto a feeder layer of irradiated
mouse embryonic ﬁbroblasts in embryonic stem (ES)
cell medium containing 80% Dulbecco’s modiﬁed
Eagle’s medium (DMEM)/F12, 20% knockout serum
replacement, 0.1 mM β-mercaptoethanol, 1 mM gluta-
mine, and 1% nonessential amino acids, supplemented
with 10 ng/ml bFGF. The iPSCs were fed every day until
ready to passage. To passage iPSCs, cells were incubated
with 1 mg/ml collagenase IV in DMEM/F12 for about
15–30 min at 37 °C. Then, the colonies were collected,
gently dissociated into small clusters, and plated in fresh
medium.
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The induction of neural precursor cells was based on a
previous report50. Brieﬂy, after digestion and trituration,
cells were resuspended in ES cell medium without FGF-2
for 6 days as ﬂoating embryonic bodies (EBs). Then,
medium was switched to N2 medium consisting of
DMEM/F12, 1% N2 supplement, 1% nonessential amino
acids, 2 µg/ml heparin, and 10 ng/ml bFGF for 10 days.
To separate the rosette clusters from the differentiating
EBs, the cells were incubated with 0.1 mg/ml dispase at
37 °C for 15–20 min. Then, the rosette clumps were
isolated, gently triturated, and plated in fresh N2 med-
ium as neural stem cells. Culture was fed every 2 or
3 days. Cells were subcultured once a week by triturating
the neurospheres after digestion with dispase. For
adhesion culture, the NSCs were cultured in matrigel-
coated plates.
To analyze the differentiation potential, NSCs were
cultured on poly-ornithine/laminin-coated plates in N2
medium without bFGF for 10 days. Medium were chan-
ged every 3 days.
Irradiation treatment
Cells were seeded at 1 × 104 cells/ml in 24-well plates
(Corning Incorporated, USA), treated with 10 Gy X-ray
irradiation, and incubated at 37 °C until the collection
time points.
Chemical molecule treatment
Cells were seeded at 1 × 104 cells/ml in 24-well plates,
pretreated with chemical molecules, and then exposed to
10 Gy X-ray irradiation followed by incubation at 37 °C
until the collection time points. The concentration of
resveratrol (Sigma) was 3 μM. The concentration of rapa-
mycin (Sigma) was 0.04 μM. The concentration of chlor-
oquine (Sigma) was 3 μM. The concentration of SB203580
(Sigma) was 20 μM. The concentration of nicotinamide
(Sigma) was 5mM.
ROS measurement
To measure intracellular ROS, cells were incubated in
2′,7′-dichloroﬂuorescein diacetate (DCF-DA) solution
(Genmed Scientiﬁcs) at 37 °C for 20min and then moved
to the Nikon E800 ﬂuorescence microscope (Nikon,
Japan). Experiments were performed in triplicates from
three independent trials.
SA-β-gal assay
Cellular senescence was determined using the SA-β-gal
staining Kit (Genmed Scientiﬁcs). Brieﬂy, after 12 h
incubation at 37 °C, the blue stained cells from 10 dif-
ferent ﬁelds were captured with an optic microscope and
were counted with results presented as a percentage of
positive cells.
CCK8 assay
For the cell viability assessment, NSCs derived from iPS
cells were plated onto 96-well plates (about 3 × 103 cells/
well). Twenty-four hours after seeding the cells, each well
was treated with 10 Gy X-ray irradiation. At the end of
each time point, 10 µl CCK8 solution (Dojindo Labora-
tories) was added to each well, and the plates were
incubated for an additional 2.5 h at 37 °C. The absorbance
of each plate at 450 nm represented a direct correlation
with the cell number in this analysis and was measured
using a standard microplate reader (Thermo Scientiﬁc
Varioskan Flash, USA).
Immunoﬂuorescence analysis
Cells were ﬁxed in 4% paraformaldehyde, then rinsed
with phosphate-buffered saline (PBS) three times. Cells
were blocked in 3% normal donkey serum in PBS for 1 h.
Cells then were incubated with primary antibody diluted
in 3% normal donkey serum in PBS at 4 °C overnight.
After that, cells were rinsed with PBS containing 0.1%
Triton X-100 (Sigma) three times and incubated with
secondary antibody for 1 h. Cell nucleus were stained with
4′,6-diamidino-2-phenylindole (Invitrogen) for 10 min
and slides were washed three times in PBS containing
0.1% Triton X-100 (Sigma). Images were obtained on a
Leica TCS SP2 confocal ﬂuorescence microscope.
Protein extraction and western blotting
Cells were harvested and lysed in lysis buffer for protein
extraction. Protein concentrations were measured by BCA
protein assay kit (Thermo Scientiﬁc). Proteins were
separated by SDS-polyacrylamide gel electrophoresis and
transferred onto polyvinylidene ﬂuoride membranes. The
membranes were incubated with primary antibodies:
rabbit anti-SIRT1 (Millipore), anti-BECN1 (Abclonal
Technology), anti-LC3B (Cell Signaling Technology),
anti-p16 (Abclonal Technology), anti-p21 (Abclonal
Technology), anti-p53 (Abclonal Technology), and mouse
anti-β-actin (Sigma) followed by incubation with horse-
radish peroxidase (HRP)-conjugated secondary antibodies
(HRP-donkey-anti-rabbit and HRP-donkey-anti-mouse)
(Santa Cruz Biotechnology). Signal was detected by an
ECL kit. The experiments were performed three times.
Immunoprecipitation and acetylation detection
Cells were lysed in lysis buffer followed by the deter-
mination of protein concentration. In order to analyze the
direct interaction between SIRT1 and autophagy-related
genes LC3B or BECN1, SIRT1 or LC3B, or BECN1 was
pulled down from total cell lysate with conjugated anti-
SIRT1 or LC3B or BECN1-agarose beads (Santa Cruz
Biotechnology), followed by LC3B or BECN1 or SIRT1
detection with rabbit anti-LC3B or BECN1 or SIRT1
Zhu et al. Cell Death and Disease          (2019) 10:105 Page 15 of 17
Ofﬁcial journal of the Cell Death Differentiation Association
antibody (Cell Signaling Technology). To analyze LC3B
and BECN1 acetylation, LC3B or BECN1 was pulled down
from total cell lysate with conjugated anti-LC3B or
BECN1-agarose beads (Santa Cruz Biotechnology), fol-
lowed by acetylation detection with rabbit anti-acetyl
lysine antibody (Cell Signaling Technology). The experi-
ments were performed three times.
Real-time quantitative PCR
For Q-PCR, total RNA was reverse-transcribed using
PrimeScriptII 1st Strand cDNA Synthesis Kit (TaKaRa).
Detection of target gene expression was performed by
using a SYBR Premix Ex Taq kit (TaKaRa) and Fluores-
cence quantitative PCR instrument (Applied Biosystems
7500 Fast Real-Time PCR Systems, Life Technologies,
CA, USA). Primers were designed using Primer 3 online
and experimentally validated. The relative expression
levels were determined by employing the 2−ΔΔCT method
normalized to housekeeping gene GAPDH. Experiments
were repeated in triplicate.
RNA interference targeting SIRT1
The anti-SIRT1 shRNA was used for SIRT1 down-
regulation (Sh-Sirt1). The plasmid carrying wild-type
SIRT1 cDNA was served for SIRT1 upregulation.
Recombinant vectors together with three lentiviral
packaging plasmids (at a 10:5:3:2 ratio) were transfected
into 293T cells using Lipofectamine 2000 (Invitrogen).
Serial dilution methods were performed to determine the
lentivirus titer. The lentivirus were used to infect NSCs at
appropriate titers. These cells were harvested 96 h after
infection, and real-time PCR and western blot analysis
were performed to determine the efﬁciency of SIRT1
downregulation and upregulation. The experiments were
repeated three times.
Transfection of cells with Beclin 1 small interference RNA
Cells were transiently transfected with small inter-
ference RNA (siRNA) of Beclin 1 (sense, GGAGCCA
UUUAUUGAAACUTT; antisense, AGUUUCAAUAAA
UGGCUCCTT) or control nonspeciﬁc siRNA (sense, UU
CUCCGAACGUGUCACGUTT; antisense, ACGUGACA
CGUUCGGAGAATT) using FuGENE HD Transfection
Reagent (Promega). Forty-eight hours after transfection,
cells were exposed to various treatments as speciﬁcally
indicated.
Autophagy detection
To further determine the induction of autophagy, the
development of acidic vesicular organelles was tested
using adenoviral vectors with mRFP-GFP-LC3, which
were obtained from HanBio Technology Co. Ltd. (Han-
Bio). After treatment, autophagosomes and autolyso-
somes were observed under confocal microscopy (Leica
TCS SP8, Germany). The total number of puncta per cell
was counted. To conﬁrm the autophagosome structures
of autophagy, cells were ﬁxed with a solution containing
3% glutaraldehyde plus 2% paraformaldehyde in 0.1M
PBS (pH= 7.3) for 1 h for further analysis by transmission
electron microscopy.
Statistical analysis
Data were analyzed by Student’s t-test and one-way
analysis of variance. Signiﬁcance was accepted at P < 0.05.
All the detailed statistical analysis was described in Sup-
plementary Table 2.
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